Skip to content

Clinical trials

Phase 3 trials in Saudi Arabia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Country / region: Saudi Arabia Clear all

288 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20044
20051
20064
20075
20088
200912
20106
201112
20128
20138
201412
20158
20168
201716
201818
201914
202017
202119
202223
202317
202424
202532
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed128
Active, not recruiting60
Recruiting57
Terminated21
Unknown status17
Not yet recruiting2
Enrolling by invitation1
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals25
AstraZeneca21
Hoffmann-La Roche16
Pfizer13
Sanofi11
King Faisal Specialist Hospital & Research Center10
Boehringer Ingelheim9
Children's Oncology Group9
King Saud University8
Imam Abdulrahman Bin Faisal University7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms19
Hemophilia A11
Anemia, Sickle Cell10
Diabetes Mellitus, Type 28
Hypertension7
Hematologic Diseases6
Hemophilia B6
Asthma5
Crohn Disease5
Multiple Sclerosis5

Trials

Showing 76 to 100 of 288. Each trial links to its page on Pharma Observatory.

188 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.